{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:28:47Z","timestamp":1786609727985,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["SJCX25_0826"],"award-info":[{"award-number":["SJCX25_0826"]}]},{"name":"Clinical Projects of Changzhou Medical Center in 2024","award":["CMCC202414"],"award-info":[{"award-number":["CMCC202414"]}]},{"name":"Top Talent of Changzhou \u201c14th Five-Year Plan\u201d High-Level Health Talents Training Project","award":["KY20241992"],"award-info":[{"award-number":["KY20241992"]}]},{"name":"Clinical Research Special Project of Changzhou First People's Hospital","award":["KY20252327"],"award-info":[{"award-number":["KY20252327"]}]},{"name":"Special Project of the Medical Affairs Department of Changzhou First People's Hospital","award":["XJSXXM-2025013"],"award-info":[{"award-number":["XJSXXM-2025013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-03020-2","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:02:48Z","timestamp":1785157368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-density lipoprotein cholesterol is inversely associated with left atrial low-voltage areas in patients with persistent atrial fibrillation: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Jiahe","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beining","family":"E","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinpeng","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"3020_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-thoracic Surgery (EACTS): The task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612.","journal-title":"Eur Heart J"},{"key":"3020_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/CIRCEP.111.966226","volume":"5","author":"S Dixit","year":"2012","unstructured":"Dixit S, Marchlinski FE, Lin D, Callans DJ, Bala R, Riley MP, et al. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol. 2012;5:287\u201394. https:\/\/doi.org\/10.1161\/CIRCEP.111.966226.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"3020_CR3","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.jacc.2012.04.060","volume":"60","author":"RR Tilz","year":"2012","unstructured":"Tilz RR, Rillig A, Thum A-M, Arya A, Wohlmuth P, Metzner A, et al. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the hamburg sequential ablation strategy. J Am Coll Cardiol. 2012;60:1921\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2012.04.060.","journal-title":"J Am Coll Cardiol"},{"key":"3020_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41569-024-01088-w","volume":"22","author":"U Schotten","year":"2025","unstructured":"Schotten U, Goette A, Verheule S. Translation of pathophysiological mechanisms of atrial fibrosis into new diagnostic and therapeutic approaches. Nat Rev Cardiol Nat Publishing Group. 2025;22:225\u201340. https:\/\/doi.org\/10.1038\/s41569-024-01088-w.","journal-title":"Nat Rev Cardiol Nat Publishing Group"},{"key":"3020_CR5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jacc.2015.06.1313","volume":"66","author":"MS Dzeshka","year":"2015","unstructured":"Dzeshka MS, Lip GYH, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with atrial fibrillation: Mechanisms and clinical implications. J Am Coll Cardiol. 2015;66:943\u201359. https:\/\/doi.org\/10.1016\/j.jacc.2015.06.1313.","journal-title":"J Am Coll Cardiol"},{"key":"3020_CR6","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1093\/eurheartj\/ehae291","volume":"45","author":"R Crowley","year":"2024","unstructured":"Crowley R, Chieng D, Sugumar H, Ling L-H, Segan L, William J, et al. Catheter ablation for persistent atrial fibrillation: Patterns of recurrence and impact on quality of life and health care utilization. Eur Heart J. 2024;45:2604\u201316. https:\/\/doi.org\/10.1093\/eurheartj\/ehae291.","journal-title":"Eur Heart J"},{"key":"3020_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1540-8167.2011.02178.x","volume":"23","author":"AW Teh","year":"2012","unstructured":"Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence SJ, et al. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease. J Cardiovasc Electrophysiol. 2012;23:232\u20138. https:\/\/doi.org\/10.1111\/j.1540-8167.2011.02178.x.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"3020_CR8","doi-asserted-by":"publisher","first-page":"e0266939","DOI":"10.1371\/journal.pone.0266939","volume":"17","author":"T Ikoma","year":"2022","unstructured":"Ikoma T, Naruse Y, Kaneko Y, Sakakibara T, Narumi T, Sano M, et al. Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation. PLoS ONE. 2022;17:e0266939. https:\/\/doi.org\/10.1371\/journal.pone.0266939.","journal-title":"PLoS ONE"},{"key":"3020_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10840-013-9838-y","volume":"39","author":"Y Lin","year":"2014","unstructured":"Lin Y, Yang B, Garcia FC, Ju W, Zhang F, Chen H, et al. Comparison of left atrial electrophysiologic abnormalities during sinus rhythm in patients with different type of atrial fibrillation. J Interv Card Electrophysiol. 2014;39:57\u201367. https:\/\/doi.org\/10.1007\/s10840-013-9838-y.","journal-title":"J Interv Card Electrophysiol"},{"key":"3020_CR10","doi-asserted-by":"publisher","first-page":"1101152","DOI":"10.3389\/fcvm.2022.1101152","volume":"9","author":"T Huang","year":"2022","unstructured":"Huang T, Nairn D, Chen J, Mueller-Edenborn B, Pilia N, Mayer L, et al. Structural and electrophysiological determinants of atrial cardiomyopathy identify remodeling discrepancies between paroxysmal and persistent atrial fibrillation. Front Cardiovasc Med. 2022;9:1101152. https:\/\/doi.org\/10.3389\/fcvm.2022.1101152.","journal-title":"Front Cardiovasc Med"},{"key":"3020_CR11","doi-asserted-by":"publisher","first-page":"euaf206","DOI":"10.1093\/europace\/euaf206","volume":"27","author":"C-A Oliva","year":"2025","unstructured":"Oliva C-A, Morello M, Kron J, Ellenbogen KA, Golino M, De Ponti R. Prevalence and multiple predictors of left atrial low voltage in paroxysmal and non-paroxysmal atrial fibrillation patients undergoing ablation: A systematic review and meta-analysis. Europace. 2025;27:euaf206. https:\/\/doi.org\/10.1093\/europace\/euaf206.","journal-title":"Europace"},{"key":"3020_CR12","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jacep.2022.03.012","volume":"8","author":"G Yang","year":"2022","unstructured":"Yang G, Zheng L, Jiang C, Fan J, Liu X, Zhan X, et al. Circumferential pulmonary vein isolation plus low-voltage area modification in persistent atrial fibrillation: The STABLE-SR-II trial. JACC Clin Electrophysiol. 2022;8:882\u201391. https:\/\/doi.org\/10.1016\/j.jacep.2022.03.012.","journal-title":"JACC Clin Electrophysiol"},{"key":"3020_CR13","doi-asserted-by":"publisher","first-page":"euad194","DOI":"10.1093\/europace\/euad194","volume":"25","author":"Z Starek","year":"2023","unstructured":"Starek Z, Di Cori A, Betts TR, Clerici G, Gras D, Lyan E, et al. Baseline left atrial low-voltage area predicts recurrence after pulmonary vein isolation: WAVE-MAP AF results. Europace. 2023;25:euad194. https:\/\/doi.org\/10.1093\/europace\/euad194.","journal-title":"Europace"},{"key":"3020_CR14","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41591-025-03674-y","volume":"31","author":"M Masuda","year":"2025","unstructured":"Masuda M, Sunaga A, Tanaka N, Watanabe T, Minamiguchi H, Egami Y, et al. Low-voltage-area ablation for persistent atrial fibrillation: A randomized controlled trial. Nat Med. 2025;31:1661\u20137. https:\/\/doi.org\/10.1038\/s41591-025-03674-y.","journal-title":"Nat Med"},{"key":"3020_CR15","doi-asserted-by":"publisher","first-page":"e858","DOI":"10.1016\/j.hrthm.2025.05.064","volume":"22","author":"A Lepillier","year":"2025","unstructured":"Lepillier A, Pineau J, Otmani A, Durand C, Waintraub X, Zakine C, et al. Pulmonary vein isolation and low-voltage area ablation in sinus rhythm for persistent atrial fibrillation: The SCAR-AF randomized trial. Heart Rhythm. 2025;22:e858\u201365. https:\/\/doi.org\/10.1016\/j.hrthm.2025.05.064.","journal-title":"Heart Rhythm"},{"key":"3020_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10840-018-0471-7","volume":"57","author":"S Ammar-Busch","year":"2020","unstructured":"Ammar-Busch S, Buiatti A, Tatzber A, Reents T, Bourier F, Semmler V, et al. Predictors of low voltage areas in persistent atrial fibrillation: Is it really a matter of time? J Interv Card Electrophysiol. 2020;57:345\u201352. https:\/\/doi.org\/10.1007\/s10840-018-0471-7.","journal-title":"J Interv Card Electrophysiol"},{"key":"3020_CR17","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/jce.16264","volume":"35","author":"AP Nordin","year":"2024","unstructured":"Nordin AP, Jensen-Urstad M, Charitakis E, Carnl\u00f6f C, Drca N. Predictors of low-voltage zones in patients with persistent atrial fibrillation eligible for catheter ablation: An observational study. J Cardiovasc Electrophys. 2024;35:1140\u20139. https:\/\/doi.org\/10.1111\/jce.16264.","journal-title":"J Cardiovasc Electrophys"},{"key":"3020_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10840-020-00882-z","volume":"62","author":"A Schade","year":"2021","unstructured":"Schade A, Costello-Boerrigter L, Steinborn F, Bayri AH, Chapran M, Surber R, et al. Voltage-guided ablation in persistent atrial fibrillation-favorable 1-year outcome and predictors. J Interv Card Electrophysiol. 2021;62:249\u201357. https:\/\/doi.org\/10.1007\/s10840-020-00882-z.","journal-title":"J Interv Card Electrophysiol"},{"key":"3020_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/CIRCEP.113.001251","volume":"7","author":"S Rolf","year":"2014","unstructured":"Rolf S, Kircher S, Arya A, Eitel C, Sommer P, Richter S, et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:825\u201333. https:\/\/doi.org\/10.1161\/CIRCEP.113.001251.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"3020_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jamacardio.2023.1749","volume":"8","author":"H Chen","year":"2023","unstructured":"Chen H, Li C, Han B, Xiao F, Yi F, Wei Y, et al. Circumferential pulmonary vein isolation with vs without additional low-voltage-area ablation in older patients with paroxysmal atrial fibrillation: A randomized clinical trial. JAMA Cardiol. 2023;8:765\u201372. https:\/\/doi.org\/10.1001\/jamacardio.2023.1749.","journal-title":"JAMA Cardiol"},{"key":"3020_CR21","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.3390\/jcm11154519","volume":"11","author":"F Squara","year":"2022","unstructured":"Squara F, Scarlatti D, Bun S-S, Moceri P, Ferrari E, Meste O, et al. Fibrillatory wave amplitude evolution during persistent atrial fibrillation ablation: Implications for atrial substrate and fibrillation complexity assessment. J Clin Med. 2022;11:4519. https:\/\/doi.org\/10.3390\/jcm11154519.","journal-title":"J Clin Med"},{"key":"3020_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.36660\/abc.20220680","volume":"119","author":"AAL Carmo","year":"2022","unstructured":"Carmo AAL. Fibrillatory wave amplitude: Should we use it routinely in clinical practice? Arq Bras Cardiol. 2022;119:789\u201390. https:\/\/doi.org\/10.36660\/abc.20220680.","journal-title":"Arq Bras Cardiol"},{"key":"3020_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10840-009-9398-3","volume":"26","author":"I Nault","year":"2009","unstructured":"Nault I, Lellouche N, Matsuo S, Knecht S, Wright M, Lim K-T, et al. Clinical value of fibrillatory wave amplitude on surface ECG in patients with persistent atrial fibrillation. J Interv Card Electrophysiol. 2009;26:11\u20139. https:\/\/doi.org\/10.1007\/s10840-009-9398-3.","journal-title":"J Interv Card Electrophysiol"},{"key":"3020_CR24","doi-asserted-by":"publisher","first-page":"e012771","DOI":"10.1161\/JAHA.119.012771","volume":"8","author":"H-J Lee","year":"2019","unstructured":"Lee H-J, Lee S-R, Choi E-K, Han K-D, Oh S. Low lipid levels and high variability are associated with the risk of new-onset atrial fibrillation. J Am Heart Assoc. 2019;8:e012771. https:\/\/doi.org\/10.1161\/JAHA.119.012771.","journal-title":"J Am Heart Assoc"},{"key":"3020_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/CIRCEP.111.966804","volume":"5","author":"FL Lopez","year":"2012","unstructured":"Lopez FL, Agarwal SK, Maclehose RF, Soliman EZ, Sharrett AR, Huxley RR, et al. Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: The atherosclerosis risk in communities study. Circ Arrhythm Electrophysiol. 2012;5:155\u201362. https:\/\/doi.org\/10.1161\/CIRCEP.111.966804.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"3020_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jacl.2019.12.002","volume":"14","author":"B Guan","year":"2020","unstructured":"Guan B, Li X, Xue W, Tse G, Waleed KB, Liu Y, et al. Blood lipid profiles and risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. J Clin Lipidol. 2020;14:133\u2013e1423. https:\/\/doi.org\/10.1016\/j.jacl.2019.12.002.","journal-title":"J Clin Lipidol"},{"key":"3020_CR27","doi-asserted-by":"publisher","first-page":"17721","DOI":"10.1038\/s41598-024-67100-y","volume":"14","author":"M Guan","year":"2024","unstructured":"Guan M, Hu H, Qi D, Qin X, Wan Q. Inverse relationship between LDL-C\/HDL-C ratio and atrial fibrillation in chronic kidney disease patients. Sci Rep. 2024;14:17721. https:\/\/doi.org\/10.1038\/s41598-024-67100-y.","journal-title":"Sci Rep"},{"key":"3020_CR28","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1161\/CIRCEP.113.001378","volume":"7","author":"S Mora","year":"2014","unstructured":"Mora S, Akinkuolie AO, Sandhu RK, Conen D, Albert CM. Paradoxical association of lipoprotein measures with incident atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:612\u20139. https:\/\/doi.org\/10.1161\/CIRCEP.113.001378.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"3020_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.12997\/jla.2023.12.1.73","volume":"12","author":"H-J Ahn","year":"2023","unstructured":"Ahn H-J, Lee S-R, Choi E-K, Lee S-W, Han K-D, Kwon S, et al. Evaluation of the paradoxical association between lipid levels and incident atrial fibrillation according to statin usage: A nationwide cohort study. J Lipid Atheroscler. 2023;12:73\u201386. https:\/\/doi.org\/10.12997\/jla.2023.12.1.73.","journal-title":"J Lipid Atheroscler"},{"key":"3020_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10840-019-00543-w","volume":"57","author":"Y Shang","year":"2020","unstructured":"Shang Y, Chen N, Wang Q, Zhuo C, Zhao J, Lv N, et al. Blood lipid levels and recurrence of atrial fibrillation after radiofrequency catheter ablation: A prospective study. J Interv Card Electrophysiol. 2020;57:221\u201331. https:\/\/doi.org\/10.1007\/s10840-019-00543-w.","journal-title":"J Interv Card Electrophysiol"},{"key":"3020_CR31","doi-asserted-by":"publisher","first-page":"28434","DOI":"10.1038\/s41598-024-79836-8","volume":"14","author":"H Zou","year":"2024","unstructured":"Zou H, Huang Q, Huang Q, Hu B, He W, Xia Z, et al. L-shaped association of plasma low-density lipoprotein cholesterol with atrial fibrillation recurrence after catheter ablation: A prospective cohort study. Sci Rep Nat Publishing Group. 2024;14:28434. https:\/\/doi.org\/10.1038\/s41598-024-79836-8.","journal-title":"Sci Rep Nat Publishing Group"},{"key":"3020_CR32","doi-asserted-by":"publisher","first-page":"e938288","DOI":"10.12659\/MSM.938288","volume":"29","author":"Z-Z Li","year":"2023","unstructured":"Li Z-Z, Liu T, Huang Q, Liu X-X, Song Y-Q, Guo X-Y, et al. Association between pre-radiofrequency catheter ablation serum lipid levels and recurrence of atrial fibrillation in 412 patients in Beijing, China: A single-center study. Med Sci Monit. 2023;29:e938288. https:\/\/doi.org\/10.12659\/MSM.938288.","journal-title":"Med Sci Monit"},{"key":"3020_CR33","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/clc.23430","volume":"43","author":"Y Yao","year":"2020","unstructured":"Yao Y, Liu F, Wang Y, Liu Z. Lipid levels and risk of new-onset atrial fibrillation: A systematic review and dose-response meta-analysis. Clin Cardiol. 2020;43:935\u201343. https:\/\/doi.org\/10.1002\/clc.23430.","journal-title":"Clin Cardiol"},{"key":"3020_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1085\/jgp.115.4.405","volume":"115","author":"I Levitan","year":"2000","unstructured":"Levitan I, Christian AE, Tulenko TN, Rothblat GH. Membrane cholesterol content modulates activation of volume-regulated anion current in bovine endothelial cells. J Gen Physiol. 2000;115:405\u201316. https:\/\/doi.org\/10.1085\/jgp.115.4.405.","journal-title":"J Gen Physiol"},{"key":"3020_CR35","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1113\/jphysiol.2007.134809","volume":"582","author":"J Abi-Char","year":"2007","unstructured":"Abi-Char J, Maguy A, Coulombe A, Balse E, Ratajczak P, Samuel J-L, et al. Membrane cholesterol modulates Kv1.5 potassium channel distribution and function in rat cardiomyocytes. J Physiol. 2007;582:1205\u201317. https:\/\/doi.org\/10.1113\/jphysiol.2007.134809.","journal-title":"J Physiol"},{"key":"3020_CR36","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","volume":"45","author":"W Khovidhunkit","year":"2004","unstructured":"Khovidhunkit W, Kim M-S, Memon RA, Shigenaga JK, Moser AH, Feingold KR, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J Lipid Res. 2004;45:1169\u201396. https:\/\/doi.org\/10.1194\/jlr.R300019-JLR200.","journal-title":"J Lipid Res"},{"key":"3020_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yjmcc.2024.05.011","volume":"193","author":"RY Medvedev","year":"2024","unstructured":"Medvedev RY, Afolabi SO, Turner DGP, Glukhov AV. Mechanisms of stretch-induced electro-anatomical remodeling and atrial arrhythmogenesis. J Mol Cell Cardiol. 2024;193:11\u201324. https:\/\/doi.org\/10.1016\/j.yjmcc.2024.05.011.","journal-title":"J Mol Cell Cardiol"},{"key":"3020_CR38","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/cvr\/cvab035","volume":"118","author":"X Li","year":"2022","unstructured":"Li X, Garcia-Elias A, Benito B, Nattel S. The effects of cardiac stretch on atrial fibroblasts: Analysis of the evidence and potential role in atrial fibrillation. Cardiovasc Res. 2022;118:440\u201360. https:\/\/doi.org\/10.1093\/cvr\/cvab035.","journal-title":"Cardiovasc Res"},{"key":"3020_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3949\/ccjm.92a.24011","volume":"92","author":"J Hartnett","year":"2025","unstructured":"Hartnett J, Chouman N, Donnellan E. Risk-factor modification to prevent recurrent atrial fibrillation after catheter ablation. Cleve Clin J Med. 2025;92:53\u201361. https:\/\/doi.org\/10.3949\/ccjm.92a.24011.","journal-title":"Cleve Clin J Med"},{"key":"3020_CR40","doi-asserted-by":"publisher","first-page":"e1004067","DOI":"10.1371\/journal.pmed.1004067","volume":"19","author":"D Sagris","year":"2022","unstructured":"Sagris D, Harrison SL, Lip GYH. Lipids and atrial fibrillation: New insights into a paradox. PLoS Med. 2022;19:e1004067. https:\/\/doi.org\/10.1371\/journal.pmed.1004067.","journal-title":"PLoS Med"},{"key":"3020_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ccep.2023.08.003","volume":"16","author":"V Malik","year":"2024","unstructured":"Malik V, Linz D, Sanders P. The role of the autonomic nervous system as both trigger and substrate in atrial fibrillation. Card Electrophysiol Clin. 2024;16:271\u201380. https:\/\/doi.org\/10.1016\/j.ccep.2023.08.003.","journal-title":"Card Electrophysiol Clin"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-03020-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:47:13Z","timestamp":1786607233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-03020-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3020"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-03020-2","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was reviewed and approved by the Medical Ethics Committee of The First People\u2019s Hospital of Changzhou (approval No. 2026 [Science and Technology Department] CL070-01). Owing to the retrospective design and use of de-identified clinical data, the requirement for written informed consent was waived by the ethics committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"180"}}